Back to Search
Start Over
Fulminant B hepatitis in a surface antigen and hepatitis B DNA-negative patient with diffuse large B-cell lymphoma after CHOP chemotherapy plus rituximab.
- Source :
-
Leukemia & lymphoma [Leuk Lymphoma] 2007 Feb; Vol. 48 (2), pp. 431-3. - Publication Year :
- 2007
- Subjects :
- Antibodies, Monoclonal therapeutic use
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Agents therapeutic use
Cyclophosphamide therapeutic use
DNA, Viral blood
Doxorubicin therapeutic use
Hepatitis B blood
Hepatitis B genetics
Hepatitis B virus metabolism
Humans
Lymphoma, B-Cell blood
Lymphoma, B-Cell complications
Lymphoma, Large B-Cell, Diffuse blood
Lymphoma, Large B-Cell, Diffuse complications
Male
Middle Aged
Prednisone therapeutic use
Rituximab
Vincristine therapeutic use
Antineoplastic Combined Chemotherapy Protocols therapeutic use
DNA, Viral genetics
Hepatitis B etiology
Hepatitis B virus genetics
Lymphoma, B-Cell drug therapy
Lymphoma, Large B-Cell, Diffuse drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1042-8194
- Volume :
- 48
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Leukemia & lymphoma
- Publication Type :
- Report
- Accession number :
- 17325912
- Full Text :
- https://doi.org/10.1080/10428190601059704